LADENBURG THALM/SH SH Stock Recommendations and Price Targets

LADENBURG THALM/SH SH logo
Ladenburg Thalmann Financial Services Inc. operates as a diversified financial services company in the United States. Its Independent Advisory and Brokerage Services segment offers advisory and securities brokerage services for clients, including advisor managed accounts, general securities, mutual funds, and variable and fixed annuities; brokerage support services, such as access to stock, bond, exchange-traded fund, and options execution; products comprising insurance, non-traded real estate investment trusts, and unit trusts; and research, compliance, supervision, accounting, and related services. This segment also provides asset management services; and trust administration of personal and retirement accounts, estate and financial planning, wealth management, and custody services. The company's Ladenburg segment offers investment banking services consisting of corporate finance services, such as underwritten public, registered direct, and at-the-market offerings, as well as private investment in public equity and other private placements; and strategic and financial advisory services. This segment also provides investment research, sales and trading, and investment services, as well as administration, operation, securities transactions processing, and customer accounts services; and various asset management products and services, including asset management programs, investment consulting services, fund management, private investment management programs, retirement plan sponsor services, alternative investments, architect programs, and third-party advisory services. Its Insurance Brokerage segment delivers life insurance, fixed, and equity indexed annuities, as well as long-term care solutions to investment and insurance providers; and marketing strategies, product expertise, and back-office processing for fixed and equity-indexed annuities. Ladenburg Thalmann Financial Services Inc. was founded in 1876 and is headquartered in Miami, Florida.
Read More

This is a list of recent ratings by LADENBURG THALM/SH SH.

DateCompany NameActionCurrent
Price
Price
Target
RatingImpact on
Share Price
1/11/2022
SRAX
SRAX
Boost Price Target$5.00$12.00 ➝ $13.50High
12/21/2021
VRDN
Viridian Therapeutics
Reiterated Rating$20.00 $36.00BuyHigh
12/1/2021
ARDX
Ardelyx
Upgrade$1.00 $6.00Neutral ➝ BuyHigh
11/30/2021
XPDI
Power & Digital Infrastructure Acquisition
Initiated Coverage$10.00 $18.75BuyHigh
11/22/2021
RPHM
Reneo Pharmaceuticals
Initiated Coverage$9.00 $45.00BuyMedium
11/18/2021
CYCC
Cyclacel Pharmaceuticals
Lower Price Target$4.00$18.00 ➝ $17.00BuyHigh
11/18/2021
FSTX
F-star Therapeutics
Lower Price Target$5.00$27.00 ➝ $15.00BuyHigh
11/17/2021
BWAY
BrainsWay
Boost Price Target$8.00$16.00 ➝ $17.00BuyLow
11/10/2021
HYRE
HyreCar
Upgrade$4.00$15.00 ➝ $10.50Neutral ➝ BuyHigh
10/29/2021
WRAP
Wrap Technologies
Lower Price Target$4.00$9.40 ➝ $6.75BuyMedium
10/19/2021
PHGE
BiomX
Reiterated Rating$2.00 $19.00BuyN/A
10/14/2021
ARDX
Ardelyx
Downgrade$1.00Buy ➝ NeutralHigh
10/14/2021
RCOR
Renovacor
Initiated Coverage$8.00 $22.00BuyHigh
10/7/2021
NBY
NovaBay Pharmaceuticals
Boost Price Target$0.00$1.90 ➝ $2.20BuyN/A
10/1/2021
BCYP
Big Cypress Acquisition
Initiated Coverage$8.00 $16.50BuyLow
9/30/2021
PTN
Palatin Technologies
Reiterated Rating$0.00 $2.00BuyN/A
9/15/2021
ITMR
Itamar Medical
Downgrade$31.00 $33.85Buy ➝ NeutralLow
9/14/2021
AADI
Aadi Bioscience
Initiated Coverage$25.00 $51.00BuyLow
9/7/2021
NLCP
NewLake Capital Partners
Initiated Coverage$27.00 $44.00BuyN/A
9/3/2021
FBRX
Forte Biosciences
Downgrade$2.00Buy ➝ NeutralN/A
8/17/2021
LRFC
Logan Ridge Finance
Upgrade$25.00 $32.00Neutral ➝ BuyHigh
8/12/2021
PAYS
PaySign
Upgrade$2.00$3.50 ➝ $3.75Neutral ➝ BuyHigh
8/11/2021
HYRE
HyreCar
Downgrade$4.00$14.00 ➝ $15.00Buy ➝ NeutralHigh
8/10/2021
LFT
Lument Finance Trust
Upgrade$3.00 $4.50Neutral ➝ BuyHigh
8/9/2021
OFS
OFS Capital
Upgrade$11.00 $11.50Neutral ➝ BuyMedium
8/9/2021
PFLT
PennantPark Floating Rate Capital
Downgrade$13.00 $13.50Buy ➝ NeutralLow
8/4/2021
RYTM
Rhythm Pharmaceuticals
Downgrade$9.00Buy ➝ NeutralHigh
8/3/2021
IMMP
Immutep
Initiated Coverage$3.00 $8.30BuyMedium
7/27/2021
ECOR
electroCore
Initiated Coverage$1.00 $0.93BuyLow
7/21/2021
LAND
Gladstone Land
Downgrade$33.00Buy ➝ NeutralHigh
7/20/2021
ARDX
Ardelyx
Boost Price Target$1.00$6.50 ➝ $15.00BuyN/A
7/19/2021
ARTL
Artelo Biosciences
Reiterated Rating$0.00 $7.00BuyLow
7/13/2021
AYLA
Ayala Pharmaceuticals
Initiated Coverage$7.00 $29.00BuyHigh
7/2/2021
HROW
Harrow Health
Initiated Coverage$8.00 $14.25BuyMedium
6/23/2021
SNCR
Synchronoss Technologies
Reiterated Rating$2.00 $7.40BuyHigh
6/23/2021
EVAX
Evaxion Biotech A/S
Reiterated RatingC$4.00 C$23.00BuyHigh
6/22/2021
XAIR
Beyond Air
Reiterated RatingC$8.00 C$17.00BuyLow
6/21/2021
OPK
OPKO Health
Initiated Coverage$5.00 $7.00BuyMedium
6/18/2021
AYTU
Aytu Biopharma
Reiterated Rating$1.00 $14.50BuyHigh
5/20/2021
GRWG
GrowGeneration
Upgrade$9.00 $45.00Neutral ➝ BuyLow
5/19/2021
LBPS
4D pharma
Initiated Coverage$4.00 $35.00BuyLow
5/18/2021
ATXS
Catabasis Pharmaceuticals
Initiated Coverage$5.00 $6.00BuyLow
5/18/2021
PAYS
PaySign
Upgrade$2.00 $3.50Sell ➝ NeutralMedium
5/14/2021
GRWG
GrowGeneration
Upgrade$9.00 $45.00Neutral ➝ BuyHigh
5/13/2021
LBPS
4D pharma
Initiated Coverage$4.00 $35.00BuyHigh
5/13/2021
TRIN
Trinity Capital
Upgrade$18.00 $17.00Neutral ➝ BuyLow
5/12/2021
PAYS
PaySign
Upgrade$2.00 $3.50Sell ➝ NeutralHigh
5/12/2021
ATXS
Catabasis Pharmaceuticals
Initiated Coverage$5.00 $36.00BuyHigh
5/12/2021
TSLX
Sixth Street Specialty Lending
Reiterated Rating$24.00Buy ➝ NeutralN/A
5/10/2021
BYRN
Byrna Technologies
Initiated Coverage$12.00 $26.50BuyN/A
5/7/2021
TRIN
Trinity Capital
Upgrade$18.00 $17.00Neutral ➝ BuyMedium
5/6/2021
TSLX
Sixth Street Specialty Lending
Downgrade$24.00Buy ➝ NeutralMedium
5/3/2021
OXSQ
Oxford Square Capital
Downgrade$4.00Buy ➝ NeutralMedium
5/3/2021
WRAP
Wrap Technologies
Initiated Coverage$4.00 $26.50BuyLow
5/3/2021
BYRN
Byrna Technologies
Initiated Coverage$12.00 $26.50BuyLow
5/3/2021
RTX
Raytheon Technologies
Upgrade$92.00 $100.00Neutral ➝ BuyLow
4/27/2021
MGP
MGM Growth Properties
Boost Price Target$39.00$36.00 ➝ $39.00Average ➝ BuyLow
4/26/2021
VICI
VICI Properties
Boost Price Target$29.00$28.00 ➝ $33.50BuyMedium
4/26/2021
NNOX
Nano-X Imaging
Initiated Coverage$12.00 $52.00BuyLow
4/26/2021
GLPI
Gaming and Leisure Properties
Boost Price Target$45.00$47.50 ➝ $51.00Low
4/21/2021
PHGE
BiomX
Initiated Coverage$2.00 $25.00BuyN/A
4/19/2021
AFCG
AFC Gamma
Initiated Coverage$20.00NeutralN/A
4/19/2021
NNOX
Nano-X Imaging
Initiated Coverage$12.00BuyHigh
4/15/2021
PHGE
BiomX
Initiated Coverage$2.00 $25.00BuyN/A
4/13/2021
IZEA
IZEA Worldwide
Upgrade$1.00 $4.50Sell ➝ NeutralHigh
4/12/2021
AFCG
AFC Gamma
Initiated Coverage$20.00NeutralN/A
4/6/2021
IZEA
IZEA Worldwide
Upgrade$1.00 $4.50Sell ➝ NeutralMedium
3/29/2021
OXSQ
Oxford Square Capital
Upgrade$4.00Neutral ➝ BuyN/A
3/23/2021
OXSQ
Oxford Square Capital
Upgrade$4.00Neutral ➝ BuyHigh
3/11/2021
CELH
Celsius
Upgrade$49.00Neutral ➝ BuyHigh
3/4/2021
SUNS
SLR Senior Investment
Reiterated Rating$15.00Buy ➝ NeutralLow
3/3/2021
KOPN
Kopin
Boost Price Target$4.00BuyHigh
3/2/2021
EVAX
Evaxion Biotech A/S
Initiated Coverage$4.00BuyHigh
2/26/2021
SUNS
SLR Senior Investment
Downgrade$15.00Buy ➝ NeutralLow
2/25/2021
NVTA
Invitae
Upgrade$12.00$46.50 ➝ $58.00Neutral ➝ BuyHigh
2/23/2021
TRIN
Trinity Capital
Initiated Coverage$18.00NeutralMedium
2/18/2021
ARR
ARMOUR Residential REIT
Downgrade$10.00Buy ➝ NeutralMedium
2/18/2021
NVTA
Invitae
Upgrade$12.00$46.50 ➝ $58.00Neutral ➝ BuyHigh
2/17/2021
OTLK
Outlook Therapeutics
Reiterated Rating$1.00 $6.00BuyLow
2/17/2021
AVXL
Anavex Life Sciences
Reiterated Rating$14.00 $20.00BuyLow
2/12/2021
ARTL
Artelo Biosciences
Initiated Coverage$0.00 $7.00BuyLow
2/12/2021
HSDT
Helius Medical Technologies
Initiated Coverage$5.00BuyLow
2/8/2021
SRAX
SRAX
Initiated Coverage$5.00 $3.50BuyHigh
2/4/2021
JUSHF
Jushi
Initiated Coverage$4.00BuyHigh
2/4/2021
APPS
Digital Turbine
Upgrade$50.00Neutral ➝ BuyHigh
1/29/2021
HYRE
HyreCar
Upgrade$4.00$7.50 ➝ $16.00Neutral ➝ BuyMedium
1/27/2021
RYTM
Rhythm Pharmaceuticals
Boost Price Target$9.00$43.00 ➝ $60.00Positive ➝ BuyHigh
1/26/2021
IZEA
IZEA Worldwide
Downgrade$1.00Neutral ➝ SellMedium
1/26/2021
BNGO
Bionano Genomics
Boost Price Target$3.00BuyHigh
1/25/2021
PSTV
Plus Therapeutics
Initiated Coverage$1.00 $8.00BuyHigh
1/25/2021
VRDN
Viridian Therapeutics
Initiated Coverage$20.00 $40.00BuyLow
1/21/2021
HYRE
HyreCar
Downgrade$4.00$6.35 ➝ $7.50Buy ➝ NeutralHigh
1/20/2021
TRXC
TransEnterix
Reiterated Rating$4.00Buy ➝ NeutralN/A
1/20/2021
UTHR
United Therapeutics
Boost Price Target$214.00$151.00 ➝ $199.00Positive ➝ BuyLow
1/19/2021
VCEL
Vericel
Boost Price Target$36.00$27.50 ➝ $44.00BuyLow
1/12/2021
GRWG
GrowGeneration
Downgrade$9.00Buy ➝ NeutralMedium
1/7/2021
SAR
Saratoga Investment
Boost Price Target$28.00$21.00 ➝ $25.00In-Line ➝ BuyLow
1/6/2021
TPST
Tempest Therapeutics
Downgrade$4.00Buy ➝ NeutralN/A
12/28/2020
CNSP
CNS Pharmaceuticals
Downgrade$1.00Buy ➝ NeutralN/A
12/23/2020
IIPR
Innovative Industrial Properties
Downgrade$210.00Buy ➝ NeutralN/A